1-8 of 8
Daniel W. Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neoadjuvant Enzalutamide Prior to Prostatectomy

Bruce Montgomery, Maria S. Tretiakova, Anthony M. Joshua, Martin E. Gleave, Neil Fleshner, Glenn J. Bubley, Elahe A. Mostaghel, Kim N. Chi, Daniel W. Lin, Martin Sanda, William Novotny, Kenneth Wu, Philip W. Kantoff, Brett T. Marck, Stephen Plymate, Steven P. Balk, Peter S. Nelson, Alvin M. Matsumoto, Rosina T. Lis, Adam Kibel, Gabriel P. Haas, Andrew Krivoshik, Alison Hannah, Mary-Ellen Taplin
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (9): 2169–2176.
https://doi.org/10.1158/1078-0432.CCR-16-1357
Published: 30 April 2017
View article titled, Neoadjuvant Enzalutamide Prior to Prostatectomy
Open the PDF for Neoadjuvant Enzalutamide Prior to Prostatectomy in another window
Includes: Supplementary data
Journal Articles

Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer

Shanshan Zhao, Milan S. Geybels, Amy Leonardson, Rohina Rubicz, Suzanne Kolb, Qingxiang Yan, Brandy Klotzle, Marina Bibikova, Antonio Hurtado-Coll, Dean Troyer, Raymond Lance, Daniel W. Lin, Jonathan L. Wright, Elaine A. Ostrander, Jian-Bing Fan, Ziding Feng, Janet L. Stanford
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1): 311–319.
https://doi.org/10.1158/1078-0432.CCR-16-0549
Published: 02 January 2017
View article titled, Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer
Open the PDF for Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study

Daniel W. Lin, Lisa F. Newcomb, Elissa C. Brown, James D. Brooks, Peter R. Carroll, Ziding Feng, Martin E. Gleave, Raymond S. Lance, Martin G. Sanda, Ian M. Thompson, John T. Wei, Peter S. Nelson, for the Canary Prostate Active Surveillance Study Investigators
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (9): 2442–2450.
https://doi.org/10.1158/1078-0432.CCR-12-3283
Published: 30 April 2013
View article titled, Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study
Open the PDF for Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study in another window
Includes: Supplementary data
Journal Articles

Prostate Cancer Mortality following Active Surveillance versus Immediate Radical Prostatectomy

Jing Xia, Bruce J. Trock, Matthew R. Cooperberg, Roman Gulati, Steven B. Zeliadt, John L. Gore, Daniel W. Lin, Peter R. Carroll, H. Ballentine Carter, Ruth Etzioni
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5471–5478.
https://doi.org/10.1158/1078-0432.CCR-12-1502
Published: 30 September 2012
View article titled, Prostate Cancer Mortality following Active Surveillance versus Immediate Radical Prostatectomy
Open the PDF for Prostate Cancer Mortality following Active Surveillance versus Immediate Radical Prostatectomy in another window
Journal Articles

Differential Gene Expression in Benign Prostate Epithelium of Men with and without Prostate Cancer: Evidence for a Prostate Cancer Field Effect

Michael C. Risk, Beatrice S. Knudsen, Ilsa Coleman, Ruth F. Dumpit, Alan R. Kristal, Nolwenn LeMeur, Robert C. Gentleman, Lawrence D. True, Peter S. Nelson, Daniel W. Lin
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (22): 5414–5423.
https://doi.org/10.1158/1078-0432.CCR-10-0272
Published: 14 November 2010
View article titled, Differential Gene Expression in Benign Prostate Epithelium of Men with and without Prostate Cancer: Evidence for a Prostate Cancer Field Effect
Open the PDF for Differential Gene Expression in Benign Prostate Epithelium of Men with and without Prostate Cancer: Evidence for a Prostate Cancer Field Effect in another window
Includes: Supplementary data
Journal Articles

Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence

Todd M. Morgan, Paul H. Lange, Michael P. Porter, Daniel W. Lin, William J. Ellis, Ian S. Gallaher, Robert L. Vessella
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (2): 677–683.
https://doi.org/10.1158/1078-0432.CCR-08-1754
Published: 15 January 2009
View article titled, Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
Open the PDF for Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence in another window
Journal Articles

Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer

Anita L. Sabichi, Seth P. Lerner, E. Neely Atkinson, H. Barton Grossman, Nancy P. Caraway, Colin P. Dinney, David F. Penson, Surena Matin, Ashish Kamat, Louis L. Pisters, Daniel W. Lin, Ruth L. Katz, Dean E. Brenner, George P. Hemstreet, III, Mary Wargo, Archie Bleyer, William H. Sanders, John L. Clifford, Howard L. Parnes, Scott M. Lippman
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (1): 224–229.
https://doi.org/10.1158/1078-0432.CCR-07-0733
Published: 02 January 2008
View article titled, Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer
Open the PDF for Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer in another window
Journal Articles

Prognostic Value of Combined “Triple”-Reverse Transcription-PCR Analysis for Prostate-Specific Antigen, Human Kallikrein 2, and Prostate-Specific Membrane Antigen mRNA in Peripheral Blood and Lymph Nodes of Prostate Cancer Patients

Ralf Kurek, German Nunez, Nikolaos Tselis, Lutz Konrad, Thomas Martin, Sandra Roeddiger, Gerd Aumüller, Nikolaos Zamboglou, Daniel W. Lin, Ulf W. Tunn, Heiner Renneberg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (17): 5808–5814.
https://doi.org/10.1158/1078-0432.CCR-1004-03
Published: 08 September 2004
View article titled, Prognostic Value of Combined “Triple”-Reverse Transcription-PCR Analysis for Prostate-Specific Antigen, Human Kallikrein 2, and Prostate-Specific Membrane Antigen mRNA in Peripheral Blood and Lymph Nodes of Prostate Cancer Patients
Open the PDF for Prognostic Value of Combined “Triple”-Reverse Transcription-PCR Analysis for Prostate-Specific Antigen, Human Kallikrein 2, and Prostate-Specific Membrane Antigen mRNA in Peripheral Blood and Lymph Nodes of Prostate Cancer Patients in another window